Patents Assigned to Leigh Biotechnology, Inc.
  • Patent number: 6380254
    Abstract: The present invention provides a method and composition for treating or preventing pathogenic effects in a mammal caused by intracellular calcium overload, comprising administering to a mammal a mixture of sodium co-transport dependent amino carboxylic acids or their physiologically acceptable salts in an amount sufficient to substantially saturate sodium-dependent amino carboxylic acid transport mechanisms of a cell's plasma membranes. Administration of these amino carboxylic acids can advantageously treat or prevent cell lysis and irreversible cell damage caused by intracellular calcium overload, especially in mammals suffering from a disease condition associated with or resulting from insufficient tissue oxygenation.
    Type: Grant
    Filed: March 12, 2001
    Date of Patent: April 30, 2002
    Assignee: Leigh Biotechnology, Inc.
    Inventors: Robert D. Pearlstein, Richard S. Kramer
  • Publication number: 20010027206
    Abstract: The present invention provides a method and composition for treating or preventing pathogenic effects in a mammal caused by intracellular calcium overload, comprising administering to a mammal a mixture of sodium co-transport dependent amino carboxylic acids or their physiologically acceptable salts in an amount sufficient to substantially saturate sodium-dependent amino carboxylic acid transport mechanisms of a cell's plasma membranes. Administration of these amino carboxylic acids can advantageously treat or prevent cell lysis and irreversible cell damage caused by intracellular calcium overload, especially in mammals suffering from a disease condition associated with or resulting from insufficient tissue oxygenation.
    Type: Application
    Filed: March 12, 2001
    Publication date: October 4, 2001
    Applicant: Leigh Biotechnology, Inc.
    Inventors: Robert D. Pearlstein, Richard S. Kramer